{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:09:51Z","timestamp":1788685791931,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10528-026-11404-3","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:19:54Z","timestamp":1781151594000},"page":"7678-7694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HILPDA, Regulated by WTAP in an m6A-Dependent Manner, Enhances Osteosarcoma Development by Inhibiting Ferroptosis and Promoting Glycolysis"],"prefix":"10.1007","volume":"64","author":[{"given":"Yong","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengji","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"11404_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11912-021-01053-7","volume":"23","author":"R Belayneh","year":"2021","unstructured":"Belayneh R, Fourman MS, Bhogal S, Weiss KR (2021) Update on osteosarcoma. Curr Oncol Rep 23:71","journal-title":"Curr Oncol Rep"},{"key":"11404_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.hoc.2025.04.005","volume":"39","author":"MW Bishop","year":"2025","unstructured":"Bishop MW (2025) Osteosarcoma: diagnosis, treatment, and emerging opportunities. Hematol Oncol Clin North Am 39:749\u2013760","journal-title":"Hematol Oncol Clin North Am"},{"key":"11404_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1053-8","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen Y, Peng C, Chen J, Chen D, Yang B, He B et al (2019) WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Mol Cancer 18:127","journal-title":"Mol Cancer"},{"key":"11404_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41419-020-02847-6","volume":"11","author":"S Chen","year":"2020","unstructured":"Chen S, Li Y, Zhi S, Ding Z, Wang W, Peng Y et al (2020) WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m(6)A-dependent manner. Cell Death Dis 11:659","journal-title":"Cell Death Dis"},{"key":"11404_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","volume":"500","author":"C Chen","year":"2021","unstructured":"Chen C, Xie L, Ren T, Huang Y, Xu J, Guo W (2021) Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs. Cancer Lett 500:1\u201310","journal-title":"Cancer Lett"},{"key":"11404_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101168","volume":"47","author":"MA de la Rosa Rodriguez","year":"2021","unstructured":"de la Rosa Rodriguez MA, Deng L, Gemmink A, van Weeghel M, Aoun ML, Warnecke C et al (2021) Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes. Mol Metab 47:101168","journal-title":"Mol Metab"},{"key":"11404_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/0118744710262369231110065230","volume":"17","author":"Z Fatemeh-Jalali","year":"2024","unstructured":"Fatemeh-Jalali Z, Mohammd S, Leila D, Maryam A, Zahra S, Soghra F et al (2024) Ferroptosis inducers as promising radiosensitizer agents in cancer radiotherapy. Curr Radiopharm 17:14\u201329","journal-title":"Curr Radiopharm"},{"key":"11404_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.950886","volume":"13","author":"Z Feng","year":"2022","unstructured":"Feng Z, Ou Y, Hao L (2022) The roles of glycolysis in osteosarcoma. Front Pharmacol 13:950886","journal-title":"Front Pharmacol"},{"key":"11404_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jhep.2023.05.009","volume":"79","author":"JC Fernandez-Checa","year":"2023","unstructured":"Fernandez-Checa JC, Torres S, Garcia-Ruiz C (2023) HILPDA, a new player in NASH-driven HCC, links hypoxia signaling with ceramide synthesis. J Hepatol 79:269\u2013272","journal-title":"J Hepatol"},{"key":"11404_CR10","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.cmet.2022.11.003","volume":"34","author":"Z Gong","year":"2022","unstructured":"Gong Z, Li Q, Shi J, Liu ET, Shultz LD, Ren G (2022) Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells. Cell Metab 34:1960-1976.e1969","journal-title":"Cell Metab"},{"key":"11404_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12943-023-01879-8","volume":"22","author":"M Han","year":"2023","unstructured":"Han M, Sun H, Zhou Q, Liu J, Hu J, Yuan W et al (2023) Effects of RNA methylation on tumor angiogenesis and cancer progression. Mol Cancer 22:198","journal-title":"Mol Cancer"},{"key":"11404_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202302575","volume":"19","author":"C He","year":"2023","unstructured":"He C, Jiang Y, Guo Y, Wu Z (2023) Amplified ferroptosis and apoptosis facilitated by differentiation therapy efficiently suppress the progression of osteosarcoma. Small 19:e2302575","journal-title":"Small"},{"key":"11404_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z et al (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6:74","journal-title":"Signal Transduct Target Ther"},{"key":"11404_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.devcel.2023.01.006","volume":"58","author":"YJ Lee","year":"2023","unstructured":"Lee YJ, Shin KJ, Jang HJ, Ryu JS, Lee CY, Yoon JH et al (2023) GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis. Dev Cell 58:320-334.e328","journal-title":"Dev Cell"},{"key":"11404_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104142","volume":"82","author":"HB Li","year":"2022","unstructured":"Li HB, Huang G, Tu J, Lv DM, Jin QL, Chen JK et al (2022) METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma. EBioMedicine 82:104142","journal-title":"EBioMedicine"},{"key":"11404_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06624-7","volume":"15","author":"A Li","year":"2024","unstructured":"Li A, Wang S, Nie J, Xiao S, Xie X, Zhang Y et al (2024) USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K\/AKT signaling pathway. Cell Death Dis 15:235","journal-title":"Cell Death Dis"},{"key":"11404_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.597860","volume":"11","author":"C Liu","year":"2021","unstructured":"Liu C, Zhou X, Zeng H, Wu D, Liu L (2021a) HILPDA is a prognostic biomarker and correlates with macrophage infiltration in pan-cancer. Front Oncol 11:597860","journal-title":"Front Oncol"},{"key":"11404_CR18","doi-asserted-by":"publisher","first-page":"e13102","DOI":"10.1111\/cpr.13102","volume":"54","author":"Y Liu","year":"2021","unstructured":"Liu Y, Huang N, Liao S, Rothzerg E, Yao F, Li Y et al (2021b) Current research progress in targeted anti-angiogenesis therapy for osteosarcoma. Cell Prolif 54:e13102","journal-title":"Cell Prolif"},{"key":"11404_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.4080","volume":"42","author":"Y Ma","year":"2024","unstructured":"Ma Y, Cong L, Shen W, Yang C, Ye K (2024) Ferroptosis defense mechanisms: the future and hope for treating osteosarcoma. Cell Biochem Funct 42:e4080","journal-title":"Cell Biochem Funct"},{"key":"11404_CR20","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1080\/15548627.2022.2150003","volume":"19","author":"J Niu","year":"2023","unstructured":"Niu J, Yan T, Guo W, Wang W, Ren T, Huang Y et al (2023) The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma. Autophagy 19:1693\u20131710","journal-title":"Autophagy"},{"key":"11404_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41419-021-04028-5","volume":"12","author":"B Ou","year":"2021","unstructured":"Ou B, Liu Y, Yang X, Xu X, Yan Y, Zhang J (2021) C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1. Cell Death Dis 12:737","journal-title":"Cell Death Dis"},{"key":"11404_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2023.110566","volume":"20","author":"Q Pan","year":"2023","unstructured":"Pan Q, Lou J, Yan P, Kang X, Li P, Huang Z (2023) WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner. Genomics 20:110566","journal-title":"Genomics"},{"key":"11404_CR23","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","volume":"86","author":"S Paul","year":"2022","unstructured":"Paul S, Ghosh S, Kumar S (2022) Tumor glycolysis, an essential sweet tooth of tumor cells. Semin Cancer Biol 86:1216\u20131230","journal-title":"Semin Cancer Biol"},{"key":"11404_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2020.06.013","volume":"493","author":"D Povero","year":"2020","unstructured":"Povero D, Johnson SM, Liu J (2020) Hypoxia, hypoxia-inducible gene 2 (HIG2)\/HILPDA, and intracellular lipolysis in cancer. Cancer Lett 493:71\u201379","journal-title":"Cancer Lett"},{"key":"11404_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jhep.2023.03.041","volume":"79","author":"D Povero","year":"2023","unstructured":"Povero D, Chen Y, Johnson SM, McMahon CE, Pan M, Bao H et al (2023) HILPDA promotes NASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia. J Hepatol 79:378\u2013393","journal-title":"J Hepatol"},{"key":"11404_CR26","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/neuonc\/noae268","volume":"27","author":"J Qiu","year":"2025","unstructured":"Qiu J, Zhao R, Ma C, Wang Q, Li B, Qi Y et al (2025) O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner. Neuro Oncol 27:900\u2013915","journal-title":"Neuro Oncol"},{"key":"11404_CR27","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302654RR","volume":"38","author":"R Ren","year":"2024","unstructured":"Ren R, Wang H, Xu Y, Wu J, Ma D, Guan W (2024) FOXS1 acts as an oncogene and induces EMT through FAK\/PI3K\/AKT pathway by upregulating HILPDA in prostate cancer. FASEB J 38:e23698","journal-title":"FASEB J"},{"key":"11404_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2310479121","volume":"121","author":"L Sainero-Alcolado","year":"2024","unstructured":"Sainero-Alcolado L, Garde-Lapido E, Snaebj\u00f6rnsson MT, Schoch S, Stevens I, Ruiz-P\u00e9rez MV et al (2024) Targeting MYC induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma. Proc Natl Acad Sci U S A 121:e2310479121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11404_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/bph.15713","volume":"179","author":"Z Shoaib","year":"2022","unstructured":"Shoaib Z, Fan TM, Irudayaraj JMK (2022) Osteosarcoma mechanobiology and therapeutic targets. Br J Pharmacol 179:201\u2013217","journal-title":"Br J Pharmacol"},{"key":"11404_CR30","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1158\/1541-7786.MCR-23-0055","volume":"22","author":"I Singh","year":"2024","unstructured":"Singh I, Rainusso N, Kurenbekova L, Nirala BK, Dou J, Muruganandham A et al (2024) Intrinsic epigenetic state of primary osteosarcoma drives metastasis. Mol Cancer Res 22:864\u2013878","journal-title":"Mol Cancer Res"},{"key":"11404_CR31","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1158\/1541-7786.MCR-18-1343","volume":"17","author":"MJ VandeKopple","year":"2019","unstructured":"VandeKopple MJ, Wu J, Auer EN, Giaccia AJ, Denko NC, Papandreou I (2019) HILPDA regulates lipid metabolism, lipid droplet abundance, and response to microenvironmental stress in solid tumors. Mol Cancer Res 17:2089\u20132101","journal-title":"Mol Cancer Res"},{"key":"11404_CR32","doi-asserted-by":"publisher","first-page":"1024915","DOI":"10.3389\/fonc.2022.1024915","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Xia G, Xiao S, Wu S, Zhang L, Huang J et al (2022) A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma. Front Oncol 12:1024915","journal-title":"Front Oncol"},{"key":"11404_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10495-023-01817-5","volume":"28","author":"K Wang","year":"2023","unstructured":"Wang K, Wang G, Li G, Zhang W, Wang Y, Lin X et al (2023) m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation. Apoptosis 28:627\u2013638","journal-title":"Apoptosis"},{"key":"11404_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/0109298665314658240712051206","volume":"31","author":"M Wang","year":"2024","unstructured":"Wang M, Li W, Han G, Bai X, Xie J (2024a) MicroRNA-605-3p inhibited the growth and chemoresistance of osteosarcoma cells via negatively modulating RAF1. Protein Pept Lett 31:559\u2013568","journal-title":"Protein Pept Lett"},{"key":"11404_CR35","doi-asserted-by":"publisher","DOI":"10.2174\/1874467217666230821142839","volume":"17","author":"S Wang","year":"2024","unstructured":"Wang S, Ren Q, Li G, Zhao X, Zhao X, Zhang Z (2024b) The targeted therapies for osteosarcoma via six major pathways. Curr Mol Pharmacol 17:e210823220109","journal-title":"Curr Mol Pharmacol"},{"key":"11404_CR36","doi-asserted-by":"publisher","first-page":"e2415814","DOI":"10.1002\/adma.202415814","volume":"37","author":"X Wang","year":"2025","unstructured":"Wang X, Guo X, Ren H, Song X, Chen L, Yu L et al (2025) An outer piezoelectric and inner epigenetic logic-gated panoptosis for osteosarcoma sono-immunotherapy and bone regeneration. Adv Mater 37:e2415814","journal-title":"Adv Mater"},{"key":"11404_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-00999-7","volume":"31","author":"C Wu","year":"2024","unstructured":"Wu C, Tan J, Shen H, Deng C, Kleber C, Osterhoff G et al (2024) Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways. J Biomed Sci 31:4","journal-title":"J Biomed Sci"},{"key":"11404_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.curpro.2025.100001","volume":"22","author":"Z Wu","year":"2025","unstructured":"Wu Z, Shen N, Song P, Wang B, Li C (2025) SP1-mediated WTAP exacerbates the progression of colon adenocarcinoma by m6A methylation of KLK8. Curr Proteomics 22:100001","journal-title":"Curr Proteomics"},{"key":"11404_CR39","doi-asserted-by":"publisher","first-page":"e23090","DOI":"10.1096\/fj.202300344RRR","volume":"37","author":"M Ye","year":"2023","unstructured":"Ye M, Chen J, Yu P, Hu C, Wang B, Bao J et al (2023) WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development. FASEB J 37:e23090","journal-title":"FASEB J"},{"key":"11404_CR40","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.2174\/1570180820666230418113909","volume":"21","author":"Z Yong","year":"2024","unstructured":"Yong Z, Tongzhou H, Qiuyan W, Jianning L (2024) Ezetimibe inhibits cell viability and invasion by suppressing PI3K\/AKT signaling pathway in human osteosarcoma cells. Lett Drug Design Discov 21:2008\u20132014","journal-title":"Lett Drug Design Discov"},{"key":"11404_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R (2022) Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer 21:47","journal-title":"Mol Cancer"},{"key":"11404_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04891-9","volume":"80","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Pang C, Zhang C, Wang Y, Wang P, Chen Y et al (2023) HILPDA-mediated lipidomic remodelling promotes radiotherapy resistance in nasopharyngeal carcinoma by accelerating mitophagy. Cell Mol Life Sci 80:242","journal-title":"Cell Mol Life Sci"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11404-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-026-11404-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11404-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:10:29Z","timestamp":1788682229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-026-11404-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11404"],"URL":"https:\/\/doi.org\/10.1007\/s10528-026-11404-3","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shiqian County People\u2019s Hospital (No.SQXRMYYLL-2025-24).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research involving animals followed the Guide for the Care and Use of Laboratory Animals and was approved by the Animal Ethics Committee of Shiqian County People\u2019s Hospital (No.SQXRMYYLL-2025025).","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}